4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathology (BETACURE)
Date du début: 1 avr. 2014, Date de fin: 31 mars 2018,
Background:Hyperinsulinaemic hypoglycaemia (HH) is a potentially lethal disease caused by over functioning beta cells derived from the pancreatic islets of Langerhans. Lethal HH and brain damage is a problem especially in infants with congenital HH. Current therapeutic approaches are associated with severe side effects/morbidity (diabetes, exocrine pancreas insufficiency etc.) considered acceptabl ...
Voir le projet
17
Participants partenaires
TERMINÉ
Improving Low Earth Orbit Security With Enhanced Electric Propulsion (LEOSWEEP)
Date du début: 21 oct. 2013, Date de fin: 1 nov. 2016,
The total mass of space debris in the low Earth orbit region is estimated to be close to 2,500 tons. About half of this mass is composed by rocket upper stages clustered in high inclination orbital regions. Because they are grouped in a relatively small number of families, acquiring the capability to deorbit just a few upper stage types would lead the way towards the elimination of hundreds of ton ...
Voir le projet
11
Participants partenaires
TERMINÉ
Miniaturized Flow Control Unit (µFCU)
Date du début: 1 déc. 2011, Date de fin: 30 sept. 2013,
"This proposal is related to FP7 space call 2011 - SPA.2011.2.2-02 (Space critical technologies). The purpose of the proposed work is the development of a miniaturized flow control unit (µFCU) for noble gases like xenon. The proposed technology is relevant to the call as it is listed in the Urgent Action List (ID 13). It is requested by space industry and agencies according ESTER database (e.g. re ...
Voir le projet
5
Participants partenaires
TERMINÉ
European IPF Network: Natural course, Pathomechanisms and Novel Treatment Options in Idiopathic Pulmonary Fibrosis (eurIPFnet)
Date du début: 1 janv. 2008, Date de fin: 30 juin 2011,
In the eurIPFnet consortium, leading European basic and clinical scientists in the field of interstitial lung diseases associate to jointly decipher the natural course and molecular pathomechanisms of Idiopathic Pulmonary Fibrosis (IPF) and to develop new therapeutic strategies for patients with IPF. This devastating disease affects about 360.000 patients in the EU and causes a substantial socioec ...
Voir le projet